1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd.

1,396.45
INR
+5.55
(+0.40%)
17.74EPS
76.03P/E
139.12BMarket Cap
Nov 05Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
28.7
33.21
36.92
45.32
44.98
53.57
66.27
79.11
82.07
Basic EPS, GAAP
4.5
6.13
8.28
10.76
8.29
11.62
13.99
16.81
17.78
Free Cash Flow per Basic Share
2.89
5.74
9.56
3.5
3.9
9.33
12.55
8.54
- -
Dividend per Share
- -
- -
- -
- -
1
1
1
2
- -
Book Value per Share
20.1
26.92
35.21
45.92
53.37
64.21
77.53
93.02
- -
Tangible Book Value per Share
19.35
26.26
34.5
45.26
52.57
50.5
63.78
79.37
- -
Basic Weighted Avg Shares
102
102
102
102
102
102
103
103
103
Sales/Revenue/Turnover
2,925
3,387
3,765
4,621
4,590
5,476
6,810
8,139
8,436
Operating Margin (%)
23.43
24.68
30.84
32.68
26.24
29.93
29.75
30.12
30.7
Depreciation Expense
396
492
505
527
617
570
706
918
947
Net Income, GAAP
459
625
845
1,097
846
1,188
1,438
1,730
1,828
Effective Tax Rate (%)
29.16
25.08
24.08
24.91
24.93
24.61
25.56
25.66
25.58
Profit Margin (%)
15.69
18.47
22.44
23.73
18.44
21.7
21.12
21.25
21.67
Working Capital
803
1,277
1,948
2,038
2,095
1,385
1,446
1,980
- -
LT Debt
1,350
1,417
1,297
1,703
2,330
2,391
2,964
4,000
- -
Total Equity
2,070
2,741
3,592
4,695
5,466
6,599
7,991
9,572
- -
Return on Invested Capital (%)
- -
16.41
18.76
19.74
12.48
14.41
14.72
14.74
- -
Return on Capital (%)
- -
18.35
20.11
20.83
13.63
15.71
15.84
15.71
- -
Return on Common Equity (%)
- -
26.08
26.67
26.52
16.71
19.77
19.79
19.74
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
226
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
4,000
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
103
103
103
Market Capitalization
109,099
88,640
139,117

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,219
- -
Cash, Cash Equivalents & STI
- -
2,877
- -
Accounts Receivable, Net
- -
209
- -
Inventories
- -
49
- -
Total Current Liabilities
- -
1,239
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
226
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
21.74%
19.77%
Free Cash Flow
- -
18.25%
-31.84%
Net Income, GAAP
- -
17.74%
20.3%
Sales/Revenue/Turnover
- -
17.05%
19.52%
Total Cash Common Dividend
- -
- -
100.18%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,562
1,829
1,690
1,732
6,810
2026
1,881
- -
2,052
2,194
8,139
2027
2,310
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
3.06
4.09
3.43
3.39
13.99
2026
3.76
- -
4.2
4.66
16.81
2027
5.16
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
2
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Suprita Reddy Sura
Full Time Employees
2,507
Sector
Health services
Industry
Medical/Nursing services
Address
FPAI Building Hyderabad TS India 500082
IPO Date
Sep 14, 2021
Website
vijayadiagnostic.com
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Vijaya Diagnostic Centre Limited, headquartered in Hyderabad, India, and founded in 1981, operates as one of India's leading diagnostic chains, providing comprehensive pathology and radiology services across a network of over 160 centres in 25 cities spanning six states including Telangana, Andhra Pradesh, Karnataka, Maharashtra, West Bengal, and the National Capital Region; core offerings encompass clinical pathology, microbiology, haematology, serology, biochemistry, molecular diagnostics, and specialized radiology modalities such as CT scans, MRI-3T, ultrasound, X-ray, PET-CT, and diagnostic cardiology, alongside over 220 basic tests, 740 routine tests, 870 specialized tests, 320 advanced radiology tests, customized health and wellness packages for diverse age groups and lifestyles, home sample collection, and corporate wellness programs. The company maintains NABL-accredited laboratories, ISO 9001:2015 certification for its flagship centre, and NABH-aligned operations, supported by more than 3,000 professionals including 300+ specialized radiologists and pathologists serving over 100 million customers. Recent developments include NCLT approval for the merger with subsidiary Medinova Diagnostic Services Limited effective April 1, 2024, alongside the completion of acquiring the remaining 37.86% stake in Medinova; expansion through commissioning nine hubs in 9MFY25 with plans for nine more hubs and six spokes, including new facilities in Bengaluru with PET-CT and 3T MRI/CT, a hub in Kasba, Kolkata, and upcoming hubs in West Bengal's Krishna Nagar and Barasat; and strong Q2 FY26 financial performance with 10.4% revenue growth to Rs 2.02 billion driven by volume increases in radiology and pathology.